Brazil In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

Product Code GMD15241
Publication Date December 2008
Publisher Global Markets Direct
Product Type Report
Pages 112
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Brazil In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

Brazil In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Brazil In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Brazil

Scope

  • The report provides in vitro diagnostics information broken down into detailed categories and segments in Brazil.
  • Total revenues, end users
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the in vitro diagnostics devices market in Brazil.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1.1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in the Report
    • 3.1 In Vitro Diagnostics Devices
    • 3.2 Clinical Chemistry Test Reagents
    • 3.3 Immunochemistry Test Reagents
    • 3.4 Blood Test Reagents
    • 3.5 Microbiology Test Reagents
    • 3.6 Infectious Immunology Test Reagents
    • 3.7 Genetic Test Reagents
    • 3.8 Self Testing
    • 3.9 Instruments
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Device Registration Protocol
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
  • 8 In Vitro Diagnostics In Brazil
    • 8.1 In Vitro Diagnostics, Brazil, Overall Revenues ($ mn), 2000-2012
    • 8.2 In Vitro Diagnostics, Brazil, Company Share (2006-2007)
  • 9 Blood Test Reagents In Brazil
    • 9.1 Blood Test Reagents Overall Revenue (2000-2012)
    • 9.2 Blood Test Reagents Distribution Share (2006-2007)
    • 9.3 Blood Test Reagents, Brazil, Company Share (2006-2007)
  • 10 Clinical Chemistry Test Reagents In Brazil
    • 10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2012)
    • 10.2 Clinical Chemistry Test Reagents Distribution Share (2006-2007)
    • 10.3 Clinical Chemistry Test Reagents, Brazil, Company Share (2006-2007)
  • 11 Genetic Test Reagents In Brazil
    • 11.1 Genetic Test Reagents Overall Revenue (2000-2012)
    • 11.2 Genetic Test Reagents Distribution Share (2006-2007)
    • 11.3 Genetic Test Reagents, Brazil, Company Share (2006-2007)
  • 12 Immunochemistry Test Reagents In Brazil
    • 12.1 Immunochemistry Test Reagents Overall Revenue (2000-2012)
    • 12.2 Immunochemistry Test Reagents Distribution Share (2006-2007)
    • 12.3 Immunochemistry Test Reagents, Brazil, Company Share (2006-2007)
  • 13 Infectious Immunology Test Reagents In Brazil
    • 13.1 Infectious Immunology Test Reagents Overall Revenue (2000-2012)
    • 13.2 Infectious Immunology Test Reagents Distribution Share (2006-2007)
    • 13.3 Infectious Immunology Test Reagents, Brazil, Company Share (2006-2007)
  • 14 Instruments In Brazil
    • 14.1 Instruments Overall Revenue (2000-2012)
    • 14.2 Instruments Distribution Share (2006-2007)
  • 15 Microbiology Test Reagents In Brazil
    • 15.1 Microbiology Test Reagents Overall Revenue (2000-2012)
    • 15.2 Microbiology Test Reagents Distribution Share (2006-2007)
    • 15.3 Microbiology Test Reagents, Brazil, Company Share (2006-2007)
  • 16 Self Testing In Brazil
    • 16.1 Self Testing Overall Revenue (2000-2012)
    • 16.2 Self Testing Distribution Share (2006-2007)
    • 16.3 Self Testing, Brazil, Company Share (2006-2007)
  • 17 Roche Diagnostics Limited Company Profile
    • 17.1 Company Overview
    • 17.2 Roche Diagnostics Limited Product Pipeline
  • 18 Abbott Laboratories Company Profile
    • 18.1 Company Overview
    • 18.2 Value Chain Analysis
  • 19 Ortho-Clinical Diagnostics Inc. Company Profile
    • 19.1 Company Overview
  • 20 Beckman Coulter, Inc. Company Profile
    • 20.1 Company Overview
    • 20.2 Value Chain Analysis
    • 20.3 Beckman Coulter, Inc. Pipeline Products
  • 21 bioMerieux S.A. Company Profile
    • 21.1 Company Overview
    • 21.2 Value Chain Analysis
  • 22 Dade Behring Holdings, Inc. Company Profile
    • 22.1 Company Overview
    • 22.2 Dade Behring Holdings, Inc. Pipeline Products
  • 23 Appendix
    • 23.1 Global Markets Direct Research Methodology
    • 23.2 Coverage
    • 23.3 Secondary Research
    • 23.4 Primary Research
    • 23.5 Models
    • 23.6 Forecasts
    • 23.7 Expert Panels
    • 23.8 Currency Conversion
    • 23.9 Contact Us
    • 23.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Medical Device Registration Fee in Brazil, 2002
    • Table 2: In Vitro Diagnostics, Brazil, Overall Revenues ($ mn), 2000-2012
    • Table 3: In Vitro Diagnostics, Brazil, Overall Revenues ($ mn), 2000-2012
    • Table 4: In Vitro Diagnostics, Brazil, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 5: In Vitro Diagnostics, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 6: In Vitro Diagnostics, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 7: Blood Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 8: Blood Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 9: Haematology Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 10: Haematology Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Table 11: Hemostasis Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 12: Hemostasis Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Table 13: Blood Test Reagents, Brazil, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 14: Blood Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 15: Clinical Chemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 16: Clinical Chemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 17: Clinical Chemistry Test Reagents, Brazil, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 18: Clinical Chemistry Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 19: Genetic Test Reagents, Brazil, Revenue ($ mn), Historic, 2000-2007
    • Table 20: Genetic Test Reagents, Brazil, Revenue ($ mn), Forecast, 2007-2012
    • Table 21: Genetic Test Reagents, Brazil, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 22: Genetic Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 23: Immunochemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 24: Immunochemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 25: Disease Specific Markers, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 26: Disease Specific Markers, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Table 27: Disease Specific Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 28: Disease Specific Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Table 29: Drug Related Testing Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 30: Drug Related Testing Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Table 31: Hormone Related Testing Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 32: Hormone Related Testing Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Table 33: Immunochemistry Test Reagents, Brazil, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 34: Immunochemistry Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 35: Infectious Immunology Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 36: Infectious Immunology Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 37: Virology, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 38: Virology, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Table 39: Infectious Immunology Test Reagents, Brazil, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 40: Infectious Immunology Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 41: Instruments, Brazil, Revenue ($ mn), Historic, 2000-2007
    • Table 42: Instruments, Brazil, Revenue ($ mn), Forecast, 2007-2012
    • Table 43: Instruments, Brazil, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 44: Microbiology Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 45: Microbiology Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 46: Bacteriology Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 47: Bacteriology Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Table 48: Microbiology Test Reagents, Brazil, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 49: Microbiology Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 50: Self Testing, Brazil, Revenue ($ mn), Historic, 2000-2007
    • Table 51: Self Testing, Brazil, Revenue ($ mn), Forecast, 2007-2012
    • Table 52: Self Testing, Brazil, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 53: Self Testing, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 54: Roche Diagnostics Limited Pipeline Products by Equipment Type
    • Table 55: Roche Diagnostics Limited Pipeline Products By Development Stage
    • Table 56: Roche Diagnostics Limited Pipeline Products By Therapy Area
    • Table 57: Roche Diagnostics Limited Pipeline Products By News Summary
    • Table 58: Beckman Coulter, Inc. Pipeline Products by Equipment Type
    • Table 59: Beckman Coulter, Inc. Pipeline Products By Development Stage
    • Table 60: Beckman Coulter, Inc. Pipeline Products By Therapy Area
    • Table 61: Beckman Coulter, Inc. Pipeline Products By News Summary
    • Table 62: Dade Behring Holdings, Inc. Pipeline Products by Equipment Type
    • Table 63: Dade Behring Holdings, Inc. Pipeline Products by Development Stage
    • Table 64: Dade Behring Holdings, Inc. Pipeline Products By Therapy Area
    • Table 65: Dade Behring Holdings, Inc. Pipeline Products By News Summary
    • Table 66: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • 1.2 List of Figures
    • Figure 1: Health Expenditure by Source in Brazil, 1996
    • Figure 2: In Vitro Diagnostics, Brazil, Overall Revenues ($ mn), 2000-2012
    • Figure 3: In Vitro Diagnostics, Brazil, Portfolio Analysis, 2007
    • Figure 4: In Vitro Diagnostics, Brazil, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 5: In Vitro Diagnostics, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 6: In Vitro Diagnostics, Brazil, Company Share (%), 2007
    • Figure 7: Blood Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 8: Blood Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 9: Haematology Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 10: Haematology Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Figure 11: Hemostasis Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 12: Hemostasis Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Figure 13: Blood Test Reagents, Brazil, Company Share (%), 2007
    • Figure 14: Clinical Chemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 15: Clinical Chemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 16: Clinical Chemistry Test Reagents, Brazil, Company Share (%), 2007
    • Figure 17: Genetic Test Reagents, Brazil, Revenue ($ mn), Historic, 2000-2007
    • Figure 18: Genetic Test Reagents, Brazil, Revenue ($ mn), Forecast, 2007-2012
    • Figure 19: Genetic Test Reagents, Brazil, Company Share (%), 2007
    • Figure 20: Immunochemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 21: Immunochemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 22: Disease Specific Markers, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 23: Disease Specific Markers, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Figure 24: Disease Specific Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 25: Disease Specific Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Figure 26: Drug Related Testing Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 27: Drug Related Testing Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Figure 28: Hormone Related Testing Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 29: Hormone Related Testing Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Figure 30: Immunochemistry Test Reagents, Brazil, Company Share (%), 2007
    • Figure 31: Infectious Immunology Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 32: Infectious Immunology Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 33: Virology, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 34: Virology, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Figure 35: Infectious Immunology Test Reagents, Brazil, Company Share (%), 2007
    • Figure 36: Instruments, Brazil, Revenue ($ mn), Historic, 2000-2007
    • Figure 37: Instruments, Brazil, Revenue ($ mn), Forecast, 2007-2012
    • Figure 38: Bacteriology Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 39: Bacteriology Test Reagents, Brazil, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Figure 40: Microbiology Test Reagents, Brazil, Company Share (%), 2007
    • Figure 41: Self Testing, Brazil, Revenue ($ mn), Historic, 2000-2007
    • Figure 42: Self Testing, Brazil, Revenue ($ mn), Forecast, 2007-2012
    • Figure 43: Self Testing, Brazil, Company Share (%), 2007
    • Figure 44: Abbott Laboratories Value Chain Analysis
    • Figure 45: Beckman Coulter, Inc. Value Chain Analysis
    • Figure 46: Biomerieux Sa Value Chain Analysis
    • Figure 47: Global Markets Direct Methodology